Cargando…

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Allogeneic hematopoietic cell transplantation (allo-HCT) is a promising treatment for adult acute lymphoblastic leukemia (ALL), an intractable hematological malignancy. The trends in allo-HCT outcomes over the past 30 years were examined to verify the efficacy of evolving treatment methods and to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishiwaki, Satoshi, Akahoshi, Yu, Morita-Fujita, Mari, Shimizu, Hiroaki, Uchida, Naoyuki, Ozawa, Yukiyasu, Fukuda, Takahiro, Tanaka, Masatsugu, Ikegame, Kazuhiro, Ota, Shuichi, Katayama, Yuta, Takahashi, Satoshi, Kawakita, Toshiro, Ara, Takahide, Onizuka, Makoto, Kimura, Takafumi, Tanaka, Junji, Atsuta, Yoshiko, Arai, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636313/ https://www.ncbi.nlm.nih.gov/pubmed/35737870 http://dx.doi.org/10.1182/bloodadvances.2022008032

Ejemplares similares

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023)

Novel risk assessment for the intensity of conditioning regimen in older patients
por: Akahoshi, Yu, et al.
Publicado: (2022)

A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group
por: Kimura, Shun-ichi, et al.
Publicado: (2023)

Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)
por: Mizumaki, Hiroki, et al.
Publicado: (2022)

Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan
por: Shimomura, Yoshimitsu, et al.
Publicado: (2022)

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2019)

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
por: Araie, Hiroaki, et al.
Publicado: (2023)

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia
por: Konuma, Takaaki, et al.
Publicado: (2022)

Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
por: Konuma, Takaaki, et al.
Publicado: (2023)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
por: Morita‐Fujita, Mari, et al.
Publicado: (2022)

Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis
por: Kurosawa, Shuhei, et al.
Publicado: (2021)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD
por: Fuji, Shigeo, et al.
Publicado: (2023)

Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation
por: Tamaki, Masaharu, et al.
Publicado: (2023)

P1265: UNRELATED FEMALE-TO-MALE BONE MARROW TRANSPLANTATION SHOULD BE PREFERRED OVER CORD BLOOD TRANSPLANTATION IN MALE RECIPIENTS.
por: Tamaki, Masaharu, et al.
Publicado: (2023)

P1323: THE PROGNOSIS AND COMPLICATIONS OF PATIENTS WITH PRE-TRANSPLANT LIVER DYSFUNCTION
por: Misaki, Yukiko, et al.
Publicado: (2023)

Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol
por: Terakura, Seitaro, et al.
Publicado: (2020)

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
por: Shigematsu, Akio, et al.
Publicado: (2015)

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
por: Gooptu, Mahasweta, et al.
Publicado: (2022)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
por: Martin, Paul J., et al.
Publicado: (2022)

EASIX-1year and late mortality after allogeneic stem cell transplantation
por: Kordelas, Lambros, et al.
Publicado: (2023)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
por: Pérez-Valencia, Amanda Isabel, et al.
Publicado: (2022)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ht40fek8sf3n71hiokpauo458o